Back to RU Rubric Capital Management LP

CHRS

11 quarters

Position history for RURubric Capital Management LP's holdings in Coherus Oncology, Inc.

No. Rubric Capital Management exited its CHRS (Coherus Oncology) position in Q3 2025. Its Q2 2025 13F listed 867,800 shares worth $634,622. Rubric Capital Management held CHRS in 9 quarterly 13F filings before exiting.

Final Value

$0

Final Shares

0

Total Value Change

-$38.3M

Total Shares Change

—

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$1.64
0
2025-Q2
Decreased
867,800
-83.5%
$634,6220.0%$0.73
0
2025-Q1
Unchanged
5.3M
0.0%
$4.2M0.1%$0.81
0
2024-Q4
Decreased
5.3M
-49.4%
$7.3M0.1%$1.38
0
2024-Q3
Unchanged
10.4M
0.0%
$10.8M0.2%$1.04
0
2024-Q2
Unchanged
10.4M
0.0%
$18M0.5%$1.73
0
2024-Q1
Increased
10.4M
+2531.5%
$24.9M0.7%$2.39
65
2023-Q4
New
395,207
-
$1.3M0.0%$3.33
35
2020-Q2
Exited
0
-100.0%
$00.0%$17.86
0
2020-Q1
Decreased
1.6M
-25.5%
$25.7M4.1%$16.22
0
2019-Q4
First report
2.1M
-
$38.3M4.3%$18.01
0

Other major holders of CHRS: Temasek Holdings (Private) Ltd, Wellington Management Group LLP

Optional analytics helps us improve. How it’s used